C07K

Watch

Stats

Description

PEPTIDES (peptides containing -lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D 519/02; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N 15/00)

Subclasses

Not Available
Subclass Title
1/00 General processes for the preparation of peptides
1/02 General processes for the preparation of peptides in solution
1/04 General processes for the preparation of peptides on carriers
1/06 General processes for the preparation of peptides using protecting groups or activating agents
1/08 General processes for the preparation of peptides using protecting groups or activating agents using activating agents

more results

Recent Patents

Not Available

Recent Publications

Not Available
Publication #TitleFiling DatePub DatePatent Owner
2018/0291,113 Bispecific CD33 and CD3 Binding Proteins Oct 27, 17 Oct 11, 18 , Not available
2018/0291,072 HUMAN-DERIVED FERRITIN MONOMER FRAGMENT AND FUSION POLYPEPTIDE USING SAME Sep 02, 16 Oct 11, 18 , KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION; Korea Institute of Science and Technology;
2018/0291,021 PDD COMPOUNDS Feb 21, 18 Oct 11, 18 , Not available
2018/0291,332 ENGINEERED CYANOBACTERIA WITH ENHANCED SALT TOLERANCE Dec 06, 17 Oct 11, 18 , MORGAN STATE UNIVERSITY
2018/0291,093 ANTI-CGRP/ANTI-IL-23 BISPECIFIC ANTIBODIES AND USES THEREOF Oct 30, 15 Oct 11, 18 , Eli Lilly and Company
2018/0291,074 DETERMINANTS OF CANCER RESPONSE TO IMMUNOTHERAPY BY PD-1 BLOCKADE Nov 23, 15 Oct 11, 18 , Not available
2018/0289,804 ANTIBODY FORMULATION Jun 13, 18 Oct 11, 18 , Not available
2018/0291,083 PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LEUKEMIAS AND OTHER CANCERS Apr 10, 18 Oct 11, 18 , Not available
2018/0291,063 ONE-BEAD-TWO-COMPOUND MACROCYCLIC LIBRARY AND METHODS OF PREPARATION AND USE Apr 06, 18 Oct 11, 18 , Not available
2018/0291,425 QUANTITATIVE ASSESSMENT FOR CAP EFFICIENCY OF MESSENGER RNA Mar 26, 18 Oct 11, 18 , Not available
2018/0291,101 HUMAZNIZED AFFINITY MATURED ANIT-FcRn ANTIBODIES Nov 13, 17 Oct 11, 18 , Not available
2018/0291,110 TRISPECIFIC ANTIBODIES SPECIFIC FOR HER2 AND A BLOOD BRAIN BARRIER RECEPTOR AND METHODS OF USE Dec 18, 17 Oct 11, 18 , Hoffmann-La Roche, Inc.
2018/0291,065 CONFORMATIONALLY-PREORGANIZED, MiniPEG-CONTAINING GAMMA-PEPTIDE NUCLEIC ACIDS May 07, 18 Oct 11, 18 , Carnegie Mellon University
2018/0291,098 ANTI-NRG1 (HEREGULIN) ANTIBODIES AND USES THEREOF Oct 26, 16 Oct 11, 18 , Not available
2018/0292,395 METHOD FOR PREDICTING RISK OF EXPOSURE TO INTERSTITIAL FIBROSIS AND TUBULAR ATROPHY WITH CLUSTERIN Nov 13, 17 Oct 11, 18 , Not available
2018/0291,085 Compositions Comprising D-Amino Acid Peptides and Methods of Production and Use Thereof for Inhibiting Autoantibodies Jun 01, 18 Oct 11, 18 , Not available
2018/0292,421 Pregabalin Immunoassays Mar 26, 18 Oct 11, 18 , Not available
2018/0291,107 COMBINATION THERAPY FOR CANCER Nov 17, 16 Oct 11, 18 , Not available
2018/0291,078 INSULIN RECEPTOR PARTIAL AGONISTS Jun 13, 18 Oct 11, 18 , Merck Sharp & Dohme Corp.
2018/0291,062 PEPTIDE COMPOSITIONS AND METHODS OF USE Apr 29, 16 Oct 11, 18 , ONL Therapeutics, Inc.; The Regents of the University of Michigan;

more results

Patents Issued To Date - By Filing Year

Average Time to Issuance

We are sorry but your current selection exceeds the maximum number of watches () for this membership level. Upgrade to our Level for up to watches!

UPGRADE MEMBERSHIP CANCEL
We are sorry but Dashboard Viewer is not able to watch the Technologies/Sub-Technologies.